Kühn, K-U <br/><br/>
Neuroimaging and 5-HT2C receptor polymorphism: a HMPAO-SPECT study in healthy male probands using mCPP-challenge of the 5-HT2C receptor.  [electronic resource] 

 -  Pharmacopsychiatry  Nov 2004 
 - 286-91 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0176-3679 
<br/><br/><label>Standard No.: </label>10.1055/s-2004-832685  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anxiety--drug therapy<br/>Brain--anatomy & histology<br/>Brain Mapping<br/>Cerebrovascular Circulation--drug effects<br/>Cysteine--metabolism<br/>Demography<br/>Double-Blind Method<br/>Humans<br/>Image Processing, Computer-Assisted--methods<br/>Male<br/>Piperazines--pharmacology<br/>Polymorphism, Genetic<br/>Receptor, Serotonin, 5-HT2C--genetics<br/>Serine--metabolism<br/>Serotonin Receptor Agonists--pharmacology<br/>Technetium Tc 99m Exametazime<br/>Tomography, Emission-Computed, Single-Photon--methods